Evidence map›Paper›PMID 42725960›Full record

Observational studyAntimicrobial agents and chemotherapy2026

Effectiveness and safety of cefazolin vs antistaphylococcal penicillins for methicillin-susceptible

Natesan Ramsamy, Maïa Simon, Isabelle Adam, Gema Hernandez, Sarah Williford, Olivier Denquin, Céline Pulcini, Nathalie Thilly, Benjamin Lefèvre

Abstract readComparative StudyMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Natesan Ramsamy *CHRU-Nancy, Service des Maladies Infectieuses et Tropicales, Université de Lorraine, Nancy, France.
Maïa Simon *Département Méthodologie Promotion Investigation, Université de Lorraine, CHRU-Nancy, Nancy, France.ORCID 0000-0003-3664-226X
Isabelle AdamDépartement Méthodologie Promotion Investigation, Université de Lorraine, CHRU-Nancy, Nancy, France.
Gema HernandezTriNetX LLC, Cambridge, Massachusetts, USA.
Sarah WillifordTriNetX LLC, Cambridge, Massachusetts, USA.
Olivier DenquinTriNetX LLC, Cambridge, Massachusetts, USA.
Céline PulciniUniversité de Lorraine, INSERM, INSPIIRE, Nancy, France.ORCID 0000-0001-5074-2270
Nathalie ThillyDépartement Méthodologie Promotion Investigation, Université de Lorraine, CHRU-Nancy, Nancy, France.ORCID 0009-0006-9665-2936
Benjamin LefèvreCHRU-Nancy, Service des Maladies Infectieuses et Tropicales, Université de Lorraine, Nancy, France.ORCID 0000-0003-0833-0904

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the effectiveness and safety of cefazolin vs antistaphylococcal penicillins (ASPs) in the treatment of methicillin-susceptible

Indexed as

Anti-Bacterial AgentsBacteremiaCefazolinPenicillinsStaphylococcal InfectionsStaphylococcus aureusAgedDatabases, FactualFemaleFirst Generation CephalosporinsHumansMaleMethicillinMiddle AgedRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsCefazolinFirst Generation CephalosporinsMethicillinPenicillinsantistaphylococcal penicillinsbacteremiacefazolinmethicillin-susceptible Staphylococcus aureusreal-word evaluationTriNetX

Identifiers

PMID42725960
PMCPMC13688797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.